Pfizer Sues Philippines Over Generic Norvasc

Law360, New York (March 8, 2006, 12:00 AM EST) -- U.S. Pharmaceutical giant Pfizer Inc. is taking on the Philippines to protect patents that cover its second best-selling drug Norvasc, only one month after a sweeping victory in U.S. courts cleared generic opposition.

Starting a new round of international litigation, Pfizer sued the Filipino government to prevent the nation from importing from India and Pakistan generic versions of the popular hypertension drug.

Pfizer filed the civil lawsuit in the Philippines after it learned that a government-owned importer and a local regulatory body allegedly planned to import...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.